FindTrial
Sign In

A Randomized, Double-Blind, Placebo-Controlled Study of the Therapeutic Effect and Safety of a Traditional Chinese Medicine (TCM) for Atopic Dermatitis in Children

A Randomized, Double-Blind, Placebo-Controlled Study of the Therapeutic Effect and Safety of a Traditional Chinese Medicine (TCM) for Atopic Dermatitis in Children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-05000734
Enrollment
Unknown
Registered
2005-09-26
Start date
2004-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin and Connective Tissue Diseases

Interventions

Two groups:Use of TCM formulation 12 weeks versus placebo

Sponsors

Department of Paediatrics
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: AD

Exclusion criteria

Exclusion criteria: active asthma oral steroids G6PDD

Design outcomes

Primary

MeasureTime frame
SCORA;—

Secondary

MeasureTime frame
steroid sue antihistamine use chemokine markers;—

Countries

China

Contacts

Public ContactChristy Kam
nil@msn.comNil

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026